Assembly Biosciences, Inc. (ASMB)
NASDAQ: ASMB · Real-Time Price · USD
24.29
-0.46 (-1.88%)
Aug 14, 2025, 1:44 PM - Market open

Assembly Biosciences Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Net Income
-38.96-40.18-61.23-93.09-129.86-62.15
Upgrade
Depreciation & Amortization
0.130.130.450.50.475.91
Upgrade
Loss (Gain) From Sale of Assets
--0.14--1.380.01
Upgrade
Asset Writedown & Restructuring Costs
----41.641.75
Upgrade
Loss (Gain) From Sale of Investments
-2.32-3.66-1.590.160.59-0.01
Upgrade
Stock-Based Compensation
3.093.125.126.595.2421.85
Upgrade
Other Operating Activities
1.141.423.513.511.31-
Upgrade
Change in Accounts Receivable
-0.040.9-0.610.892.14
Upgrade
Change in Accounts Payable
-0.060.12-2.03-0.17-1.942.87
Upgrade
Change in Unearned Revenue
-18.02-13.2983.56--6.25-28.06
Upgrade
Change in Other Net Operating Assets
-0.851.18-6.09-1.35-4.1-7.26
Upgrade
Operating Cash Flow
-55.85-51.1222.74-84.46-93.4-62.96
Upgrade
Capital Expenditures
--0.03-0.26-0.1-3.1-0.47
Upgrade
Sale of Property, Plant & Equipment
--0.021.52.36-
Upgrade
Sale (Purchase) of Intangibles
------1.75
Upgrade
Investment in Securities
41.3740.2-68.9189.2427.2570.29
Upgrade
Investing Cash Flow
41.3740.17-69.1490.6426.5268.07
Upgrade
Issuance of Common Stock
19.2729.4513.820.6153.067.6
Upgrade
Financing Cash Flow
19.2729.4513.820.6153.067.6
Upgrade
Net Cash Flow
4.818.5-32.586.79-13.8212.71
Upgrade
Free Cash Flow
-55.85-51.1522.49-84.57-96.49-63.43
Upgrade
Free Cash Flow Margin
-167.98%-179.33%313.95%--1542.88%-80.18%
Upgrade
Free Cash Flow Per Share
-7.96-8.524.91-20.96-26.75-21.48
Upgrade
Cash Income Tax Paid
0.420.42----
Upgrade
Levered Free Cash Flow
-15.97-15.71-8.2-48.91-62.75-10.96
Upgrade
Unlevered Free Cash Flow
-15.97-15.71-8.2-48.91-62.75-10.96
Upgrade
Change in Working Capital
-18.93-11.9576.34-2.12-11.4-30.31
Upgrade
Updated May 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q